United States · FDA National Drug Code directory
Divalproex sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-532_4a80fbd7-7c2d-1730-c785-1197d9bdc8e6
- Product NDC
- 55111-532
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Divalproex sodium
- Labeler
- Dr. Reddy's Laboratories Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090123
- Source listing expiry
- 20271231
Source-listed ingredients
- DIVALPROEX SODIUM — 125 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-532-01) · 55111-532-01
- 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-532-05) · 55111-532-05
- 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-532-30) · 55111-532-30
- 10 BLISTER PACK in 1 CARTON (55111-532-78) / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (55111-532-79) · 55111-532-78
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →